NPT-IIb Inhibition Does Not Improve Hyperphosphatemia in CKD

INTRODUCTION: Serum phosphate levels are insufficiently controlled in many patients with end-stage renal disease (ESRD), and novel therapeutic strategies are needed. Blocking intestinal phosphate absorption mediated by sodium-dependent phosphate co-transporter type 2b (NPT-IIb) holds promise; thus,...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsson, Tobias E., Kameoka, Chisato, Nakajo, Ikumi, Taniuchi, Yuta, Yoshida, Satoshi, Akizawa, Tadao, Smulders, Ronald A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762974/
https://www.ncbi.nlm.nih.gov/pubmed/29340316
http://dx.doi.org/10.1016/j.ekir.2017.08.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762974/
https://www.ncbi.nlm.nih.gov/pubmed/29340316
http://dx.doi.org/10.1016/j.ekir.2017.08.003

Ejemplares similares